Patient Access to ESRD New Innovative Devices Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 22, 2021)
Patient Access to ESRD New Innovative Devices Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must provide for a three-year temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD. (CMS regulations currently provide a two-year temporary add-on payment adjustment.)
What just happenedSep 23, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 22, 2021
- Sep 23, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 22, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 22, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Sep 22, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Sep 22, 2021IntroReferralIntro-H
Introduced in House
- Sep 22, 2021IntroReferral1000
Introduced in House